China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multimodal Imaging Fusion for the Classification and Prognostic Prediction of Breast Tumors'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136672
Registration Time: 2026/11/13
Type: Observational study
Primary Sponsor: Zhejiang Cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348666
Published by HT Digital Content Services with permission from Health Daily Digest....